World Aids Day
The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change. Despite the significant strides made in treatment and prevention, the confusion surrounding the relationship between HIV and AIDS still persists.
Young people have become influential advocates in the fight against HIV/AIDS. Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities. These young activists utilize digital platforms and peer-to-peer education to dispel myths, promote safe practices, and foster supportive environments for those affected by HIV/AIDS.
Dr Gowri Kulkarni, an expert in Internal Medicine, explains that while the terms HIV and AIDS are often used interchangeably, they are distinctly different. "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, whereas AIDS (Acquired Immunodeficiency Syndrome) is a condition that occurs when HIV severely damages the immune system," she clarifies. To understand the implications of these differences, it's important to explore the fundamental distinctions between the two.
HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.
AIDS, on the other hand, is a syndrome, not a virus. Dr Kulkarni further elaborates that AIDS is a collection of symptoms and illnesses that emerge when the immune system is severely compromised due to prolonged HIV infection. It represents the most advanced stage of HIV, and is characterized by very low CD4 counts or the onset of opportunistic infections like tuberculosis, pneumonia, or certain cancers.
A key distinction to remember is that not everyone with HIV will progress to AIDS. Thanks to advancements in medicine, particularly antiretroviral therapy (ART), individuals living with HIV can manage the virus and maintain a healthy immune system for many years, or even decades, without ever developing AIDS. ART works by suppressing the virus to undetectable levels, effectively preventing the damage HIV would otherwise cause to the immune system.
Without treatment, however, HIV progresses through three stages:
- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.
- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.
- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.
Another key distinction between HIV and AIDS is the way in which they are transmitted. HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, or from mother to child during childbirth or breastfeeding.
AIDS, however, is not transmissible. It is not a disease that can be passed from one person to another. Rather, AIDS is the result of untreated, advanced HIV infection and is a direct consequence of the virus’s damage to the immune system.
HIV and AIDS are diagnosed through different methods. HIV is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.
AIDS, on the other hand, is diagnosed using more specific criteria. Dr Kulkarni notes that the diagnosis of AIDS is made when the individual’s CD4 cell count falls below 200 cells/mm³, or when opportunistic infections or certain cancers (such as Kaposi's sarcoma or lymphoma) are detected. Diagnosing AIDS involves a more thorough assessment of the individual’s immune function and overall health, as opposed to just the detection of HIV.
The treatment goals for HIV and AIDS differ significantly, although both involve antiretroviral therapy (ART). For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to ART.
For individuals diagnosed with AIDS, the treatment plan becomes more complex. While ART remains an essential part of managing the virus, treatment for AIDS also focuses on addressing the opportunistic infections and secondary health complications associated with severe immune suppression. The goal of treatment for AIDS is not only to manage the HIV virus but also to improve the quality of life and extend survival by treating these secondary health issues.
While the medical community has made great strides in managing HIV, the battle to curb its transmission is also a social and cultural issue. Dr Daman Ahuja, a public health expert, highlights that HIV/AIDS awareness and education are vital to reducing transmission rates and supporting those affected by the virus. "Young people, especially, have become key advocates in the fight against HIV/AIDS," says Dr Ahuja. "Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities."
Additionally, grassroots activism plays a significant role in raising awareness and addressing stigma. As the World Health Organization reports, community-based interventions have been proven to increase HIV testing rates and improve treatment adherence, which are crucial in the fight against the pandemic.
The ultimate goal of organizations like UNAIDS is to eliminate the HIV/AIDS pandemic by 2030. Achieving this requires global collaboration, from medical treatment advancements to public health strategies, education, and advocacy. Dr Kulkarni’s insight underscores the importance of early detection, treatment adherence, and community support in the fight against HIV/AIDS.
Dr Gowri Kulkarni is Head of Medical Operations at MediBuddy and Dr Daman Ahuja, a public health expert and has been associated with Red Ribbon Express Project of NACO between 2007-12.
Credit: Canva
Wondering if abnormal bleeding, pelvic pain and leg swelling are signs of something fatal?
According to Dr Ninad Katdare, Consultant Surgical Oncologist, Jaslok Hospital & Research Centre, they may be symptoms of cervical cancer. While many may expect drastic signs such as severe pain, heavy bleeding or obvious illness, identifying certain symptoms can help with early diagnosis and treatment.
Cervical cancer develops in a women's cervix (uterus opening) due to abnormal cell growth, primarily caused by persistent HPV infection, a common infection that's passed through sexual contact.
When exposed to HPV, the body's immune system typically prevents the virus from causing damage however, in a small percentage of people, the virus can survive for years and pave the way for some cervical cells to become cancerous.
Treatment involves surgery, radiation, and chemotherapy, with early detection significantly improving outcomes, though it remains a major cancer in low-income countries. Cervical cancer can also be prevented through vaccination and regular screening (Pap/HPV tests).
Dr Katdare told News18: "In its early stages, it is often more of a whisper than a shout. As a cancer surgeon who has treated hundreds of women with gynaecological cancers, I can say with confidence that recognising these subtle cues can lead to earlier diagnosis and significantly better outcomes."
He recommends looking out for these early signs:
But Dr Katdare warns that any sudden or abnormal changes in discharge may be a symptom of the cancer. “Because discharge issues are commonly linked to infections, many women self-medicate or delay seeking care," he said. “While infections are far more common, chronic or unusual discharge especially in older women requires thorough evaluation."
Discharge may become persistent, watery, foul-smelling, or tinged with blood or pink, brown, or rust-colored if you're suffering from this kind of cancer.
Consistent pelvic pain particularly that occurs outside the menstrual cycle or during sexual intercourse should be a point of concern. According to Dr Katdare, "Pain during intercourse, or dyspareunia, is especially important. It should not be dismissed as ‘just dryness’ or an age-related change. In cervical cancer, this pain may result from inflammation or tumour growth involving the cervix and surrounding tissues."
“These symptoms are often evaluated in isolation because they don’t seem related to the cervix," said Dr Katdare, “which can delay the correct diagnosis."
Ultimately the expert advised: "“Cervical cancer does not always announce itself loudly,. Sometimes, it leaves silent clues. The sooner you listen to them, the better the outcome. If something feels ‘off,’ trust that instinct and seek medical advice. Early action can make the difference between a curable disease and a life-altering diagnosis."
Credit: Canva
Angina, a symptom of coronary artery disease, is a type of chest pain caused by the heart muscle not getting enough oxygen-rich blood, usually due to narrowed coronary arteries from plaque buildup.
Itis often described as squeezing, pressure, or heaviness in the chest, potentially radiating to arms, neck, jaw, or back and at times, can feel like indigestion. Experiencing an angina is warning sign of heart disease, not of a heart attack.
However, Shexiang Tongxin Dropping Pill (STDP), a Chinese traditional medicine that can help ease angina pain as it helps improve blood flow and protects heart microcirculation through its anti-inflammatory, anti-oxidant and anti-apoptotic (promoting cell survival) characteristics, according to an EMJ study.
In this a randomized controlled study, 200 adults with angina and coronary slow flow phenomenon were assigned to receive either STDP or a placebo. The study measured coronary blood flow using corrected TIMI frame count (CTFC).
Patients who received STDP had improved blood flow in two major coronary arteries, while those given placebo showed no improvement. The improvement with STDP was significantly greater than with placebo.
The scientists concluded that using STDP to increase blood flow in the body was beneficial with no major safety concerns reported during the trial, allowing them to conclude that this Chinese medication can help the flow of blood through the heart’s smallest blood vessels, which supply oxygen and nutrients to the heart muscle with no side-effects.
Researchers are yet to conclude how the medication works and helps the heart.
Despite being as a common heart disease, coronary artery disease (CAD) develops over years and has no clear signs and symptoms apart from chest pain and a heart attack. The illness begins due to a buildup of fats, cholesterol and other substances known as plaque in and on the artery walls.
Over time, this can cause narrowing or blockage of the coronary arteries and block the supply of oxygen-rich blood to heart which can lead chest pain (angina), shortness of breath and ultimately, heart attacks.
Typically, those above the age of 45, having a biological family member with heart disease, lack of sleep, smoking, consuming saturated fats along with other autoimmune diseases such as lupus and rheumatoid arthritis can increase the risk of developing CAD.
Treatment options may include medicines and surgery. Eating a nutritious diet, getting regular exercise and not smoking can help also prevent CAD and the conditions that can cause it.
Nearly one in 10 Indian adults suffer from CAD and about two million people die from the disease annually. Apart from this, about 18 to 20 million American adults aged 20 and older are also affected about the disease.
Moreover, regular exercise can also reduce the risk of Type 2 diabetes, high blood pressure, dementia and Alzheimer’s, several types of cancer. It can also help improve sleep, cognition, including memory, attention and processing speed.
Dr Hayes recommends opting for a cardiac evaluation such as an electrocardiogram, or EKG; stress test; a cardiac MRI or CT scan to generate images of your heart if you notice changes in your ability to exercise or cannot perform consistent levels of exercise.
Credits: Canva
In early January, the U.S. Centers for Disease Control and Prevention (CDC) made one of the most significant changes to childhood vaccination policy in decades. Routine vaccination is no longer universally recommended for six diseases, including rotavirus, influenza, meningococcal disease and hepatitis A. The move follows a directive from President Donald Trump’s administration to reassess vaccine schedules and align them with what officials called “international consensus.”
Supporters of the change describe it as a step toward informed consent and transparency. Many public health experts see it very differently. They argue that the science behind the decision is selective, the process breaks with long-standing norms, and the consequences may only become clear years later.
So are these vaccines actually necessary, and is removing them from compulsory recommendation a reasonable move? Health and Me ran a fact check to see whether the four vaccines removed from the CDC universal guidelines would actually be a "better thing", as the Health Secretary and long time vaccine critic Robert F Kennedy Jr says.
Until recently, the CDC recommended routine childhood vaccination against 17 diseases. That number has now dropped to 11. Vaccines for rotavirus, influenza, meningococcal disease, hepatitis A, hepatitis B and COVID-19 are no longer universally recommended for all children. Instead, they fall under shared clinical decision-making, meaning parents can still opt for them after discussion with a healthcare provider.
Importantly, this does not mean the vaccines are banned or unavailable. Insurance coverage remains largely unchanged for now, and vaccines remain recommended for children at higher risk.
The larger concern raised by experts is not access, but messaging. Universal recommendations have historically been one of the strongest drivers of vaccine uptake.
Read More: CDC Vaccine Schedule: Coverage Falls From 17 to 11 Diseases For Children
Traditionally, changes to the U.S. vaccine schedule go through the CDC’s Advisory Committee on Immunization Practices, a panel of independent experts who review evidence publicly over months. This time, that process was bypassed.
Instead, the decision relied on a 33-page internal assessment prepared by two political appointees. Several experts criticized both the lack of transparency and the narrow interpretation of evidence.
Dr. Paul Offit, a pediatrician and vaccine expert at Children’s Hospital of Philadelphia, described the process as federal officials making sweeping decisions behind closed doors, without public input or broad expert review.
Rotavirus causes severe diarrhea and vomiting in infants and young children, often leading to dehydration. Before routine vaccination began in 2006, an estimated 55,000 to 70,000 U.S. children were hospitalized each year due to rotavirus.
The administration justified dropping the universal recommendation by emphasizing low mortality rates. However, CDC researchers previously estimated 20 to 60 deaths annually in the pre-vaccine era. Experts say focusing narrowly on death counts ignores the very real suffering and healthcare burden the virus caused.
Offit, who helped develop one of the vaccines, noted that most pediatric residents today have never seen a child hospitalized with severe rotavirus dehydration. That absence, he argues, is proof of success, not irrelevance.
Meningococcal disease is uncommon, but when it strikes, it can be deadly within hours. Even with treatment, about 15 percent of patients die, and up to 20 percent suffer permanent complications such as amputations or hearing loss.
The administration cited low incidence and World Health Organization thresholds to justify removing the universal recommendation. But experts counter that low incidence is precisely what vaccination programs aim to achieve.
Dr. David Stephens of Emory University pointed out that most high-income countries still recommend meningococcal vaccines, even with similarly low disease rates. He also warned that recent U.S. data show a resurgence, with 2024 recording the highest number of cases in over a decade.
Modeling studies suggest that U.S. vaccination programs have already prevented hundreds of cases and dozens of deaths. Removing universal recommendations, experts warn, risks reversing those gains.
Annual flu vaccination for children has been recommended since 2008, based on evidence that children both suffer from influenza and play a major role in spreading it.
The administration argued that randomized controlled trials have not proven flu vaccines reduce hospitalizations or deaths in children. What it did not emphasize is that such trials are not designed to detect rare outcomes like death.
Dr. Mark Loeb of McMaster University explained that proving mortality benefits would require trials involving millions of children, which is not feasible. Instead, real-world observational studies are used.
Those studies consistently show that flu vaccination reduces hospitalizations in children. A 2024 review in the New England Journal of Medicine estimated a 67 percent reduction in pediatric hospital admissions. Experts say dismissing this evidence reflects a misunderstanding of how vaccine effectiveness is measured.
Also Read: RSV Vaccine Has Benefits, Reveals Study Amid CDC's Changed Guidelines On Childhood Vaccines
Hepatitis A rarely causes severe illness in young children, which is precisely why childhood vaccination works. Children often spread the virus silently to adults, who face much higher risks of liver failure and death.
Dr. Noele Nelson, a former CDC epidemiologist, explained that vaccinating children interrupts this transmission chain and provides lifelong immunity. She warned that reducing childhood vaccination could recreate the conditions that once fueled adult outbreaks.
Claims that hepatitis A vaccines lack adequate safety data were also disputed. Clinical trials and decades of post-licensure monitoring have found no unexpected safety concerns, according to Nelson and other experts.
Public health experts broadly agree that these vaccines are not perfect and that honest discussions about risks and benefits matter. Where they strongly disagree is the idea that low disease rates or ethical limits on trial design justify weakening universal recommendations.
Low incidence, experts emphasize, is not a reason to stop vaccinating. It is evidence that vaccination works.
Whether the consequences of this policy shift emerge in five years or ten, many experts fear the costs will be paid quietly, through preventable hospitalizations, outbreaks and deaths that no longer make headlines but never needed to happen in the first place.
© 2024 Bennett, Coleman & Company Limited